CIK 0001023024
- Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 582301143
- Phone
- +1 609-759-1810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,359,736
- in 11 filings, $2.4M under 10b5-1 plans
Net −$2,359,736. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-03-19 | RAYNOR DANIEL Director | Sale | −5,313 | $60.62 | $322K | 289,003 |
| 2018-03-15 | RAYNOR DANIEL Director | Sale | −1,902 | $61.50 | $117K | 294,316 |
| 2018-03-14 | RAYNOR DANIEL Director | Sale | −1,919 | $62.02 | $119K | 296,218 |
| 2018-03-13 | RAYNOR DANIEL Director | Sale | −14,000 | $61.81 | $865K | 302,254 |
| 2018-03-13 | RAYNOR DANIEL Director | Sale | −4,117 | $62.59 | $258K | 298,137 |
| 2018-03-12 | RAYNOR DANIEL Director | Sale | −7,928 | $62.88 | $499K | 316,254 |
| 2017-03-31 | RAYNOR DANIEL Director | Grant or award | +1,000 | 11,110 | ||
| 2017-03-31 | RAYNOR DANIEL Director | Grant or award · Stock Options | +2,000 | 2,000 | ||
| 2016-04-07 | RAYNOR DANIEL Director | Grant or award | +1,000 | 10,110 | ||
| 2016-04-07 | RAYNOR DANIEL Director | Grant or award · Option to Purchase | +2,000 | 2,000 | ||
| 2015-04-16 | RAYNOR DANIEL Director | Grant or award | +800 | 9,110 | ||
| 2015-04-16 | RAYNOR DANIEL Director | Grant or award · Option to Purchase | +1,600 | 1,600 | ||
| 2015-03-12 | RAYNOR DANIEL Director | Sale | −200,000 | $63.00 | $12.6M | 324,182 |
| 2014-04-01 | RAYNOR DANIEL Director | Grant or award · Option to Purchase | +2,500 | 2,500 | ||
| 2014-03-14 | RAYNOR DANIEL Director | Sale | −12,347 | $33.85 | $418K | 524,182 |
| 2014-03-12 | RAYNOR DANIEL Director | Sale | −19,213 | $33.85 | $650K | 538,427 |
| 2014-03-12 | RAYNOR DANIEL Director | Sale | −1,898 | $34.35 | $65K | 536,529 |
| 2014-03-12 | RAYNOR DANIEL Director | Sale | −21,111 | $33.89 | $715K | 3,324,738 |
| 2013-11-01 | RAYNOR DANIEL Director | Grant or award | +8,310 | 8,310 |
Page 1 of 1 · 19 trades